tiprankstipranks
Trending News
More News >
Innate Pharma (IPHA)
NASDAQ:IPHA

Innate Pharma (IPHA) Similar Stocks

Compare
131 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Top Analysts' Price Target
Smart Score
Follow
Innate Pharma
$1.70
$168.00M
-2.93
-19.43%
2 Buy
1 Hold
0 Sell
Moderate Buy
SELLAS Life Sciences Group
$1.91
$404.54M
-10.00
181.19%
2 Buy
0 Hold
0 Sell
Moderate Buy
Sangamo Biosciences
$0.42
$149.74M
-0.96
-83.08%
1 Buy
2 Hold
0 Sell
Moderate Buy
Genfit SA
$5.42
$219.11M
53.16%
2 Buy
0 Hold
0 Sell
Moderate Buy
Elicio Therapeutics
$8.19
$143.24M
-2.38
59.17%
2 Buy
0 Hold
0 Sell
Moderate Buy
Vor Biopharma
$14.53
$318.36M
-42.05%
5 Buy
1 Hold
0 Sell
Strong Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
IPHA
Innate Pharma
1.70
-0.41
-19.43%
SLS
SELLAS Life Sciences Group
2.84
1.86
189.80%
SGMO
Sangamo Biosciences
0.44
-2.12
-82.81%
GNFT
Genfit SA
5.82
2.12
57.30%
ELTX
Elicio Therapeutics
8.07
2.92
56.70%
VOR
Vor Biopharma
14.72
-10.68
-42.05%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts